REGINA SIMPSON: Open Payments
NPI 1891202628 · DUFFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 32 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $389 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $181 |
| Novo Nordisk Inc | 6 | $93 |
| ABBVIE INC. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Abbott Laboratories | 3 | $55 |
| Exact Sciences Corporation | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: FARXIGA, CAPLYTA, Ozempic, FREESTYLE LIBRE 3, UBRELVY, BREZTRI, Cologuard Collection Kit, Rybelsus.
Industry payments across VA — which companies pay providers there.
